Some drug-like compounds can spontaneously self-assemble into nanoparticles under physiological conditions. While these colloidal drug aggregates have traditionally been seen as nuisances in drug screening and formulation, their unique properties hint at interesting applications in drug delivery. I will research strategies to engineer colloidal drug aggregates as vehicles for cancer drug delivery.


PhD. student at University of Toronto
Department of Chemical Engineering and Applied Chemistry
Institute of Biomaterials and Biomedical Engineering

Completed BASc. at Queen’s University
Major in Engineering Chemistry


QEII-GSST (2018)

Nano Today Review Biography

Eric Donders is a Ph.D. student in Prof. Molly Shoichet’s group at the University of Toronto. Previously, he completed his B.A Sc. in Engineering Chemistry at Queen’s University in Kingston, Ontario. Currently, Eric researches strategies to control the stability of colloidal drug aggregates, with the goal of using these drug-rich assemblies as vehicles for drug delivery.

PhD Candidate, 2016 - Present